These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 21283312)

  • 21. Comparison of fecal occult blood tests for detection of gastrointestinal bleeding in pediatric patients.
    Rosenthal P; Jennings MT
    Am J Gastroenterol; 1992 Nov; 87(11):1575-9. PubMed ID: 1442676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reassessing the role of radiology in Hemoccult screening.
    Feczko PJ; Halpert RD
    AJR Am J Roentgenol; 1986 Apr; 146(4):697-701. PubMed ID: 3485342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HemoQuant, a new quantitative assay for fecal hemoglobin. Comparison with Hemoccult.
    Ahlquist DA; McGill DB; Schwartz S; Taylor WF; Ellefson M; Owen RA
    Ann Intern Med; 1984 Sep; 101(3):297-302. PubMed ID: 6465700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests.
    Ahlquist DA; Wieand HS; Moertel CG; McGill DB; Loprinzi CL; O'Connell MJ; Mailliard JA; Gerstner JB; Pandya K; Ellefson RD
    JAMA; 1993 Mar; 269(10):1262-7. PubMed ID: 8437303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between patterns of bleeding and Hemoccult sensitivity in patients with colorectal cancers or adenomas.
    Macrae FA; St John DJ
    Gastroenterology; 1982 May; 82(5 Pt 1):891-8. PubMed ID: 7060910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of new occult blood tests for detection of colorectal neoplasia.
    St John DJ; Young GP; Alexeyeff MA; Deacon MC; Cuthbertson AM; Macrae FA; Penfold JC
    Gastroenterology; 1993 Jun; 104(6):1661-8. PubMed ID: 8500724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interference of plant peroxidases with guaiac-based fecal occult blood tests is avoidable.
    Sinatra MA; St John DJ; Young GP
    Clin Chem; 1999 Jan; 45(1):123-6. PubMed ID: 9895348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modification of the Hemoccult slide test for occult blood in gastric juice.
    Long PC; Wilentz KV; Sudlow G; Skillman JJ
    Crit Care Med; 1982 Oct; 10(10):692-3. PubMed ID: 6981490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost benefits of hemoccult screening for colorectal carcinoma.
    Allison JE; Feldman R
    Dig Dis Sci; 1985 Sep; 30(9):860-5. PubMed ID: 3928287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for colorectal cancer using the faecal occult blood test, hemoccult.
    Towler BP; Irwig L; Glasziou P; Weller D; Kewenter J
    Cochrane Database Syst Rev; 2000; (2):CD001216. PubMed ID: 10796760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunochemical versus guaiac occult blood stool tests: results of a community-based screening program.
    Petrelli N; Michalek AM; Freedman A; Baroni M; Mink I; Rodriguez-Bigas M
    Surg Oncol; 1994 Feb; 3(1):27-36. PubMed ID: 8186868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening of first degree relatives of patients operated for colorectal cancer: evaluation of fecal calprotectin vs. hemoccult II.
    Kristinsson J; Nygaard K; Aadland E; Barstad S; Sauar J; Hofstad B; Stray N; Stallemo A; Haug B; Ugstad M; Tøn H; Fuglerud P
    Digestion; 2001; 64(2):104-10. PubMed ID: 11684824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iron overdose and detection of gastrointestinal bleeding with the hemoccult and gastroccult assays.
    Tunget CL; Clark RF; Manoguerra AS; Turchen SG
    Ann Emerg Med; 1995 Jul; 26(1):54-7. PubMed ID: 7793721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening.
    Lansdorp-Vogelaar I; van Ballegooijen M; Zauber AG; Habbema JD; Kuipers EJ
    J Natl Cancer Inst; 2009 Oct; 101(20):1412-22. PubMed ID: 19779203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reproducibility and diagnostic value of Hemoccult-II test. A colonoscopic evaluation in asymptomatic patients.
    Adamsen S; Kronborg O; Hage E; Fenger C
    Scand J Gastroenterol; 1985 Nov; 20(9):1073-7. PubMed ID: 4089518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Moisture content of Hemoccult slides influences test sensitivity.
    Faure H; Exbrayat C; Winckel P; Bolla M
    Eur J Gastroenterol Hepatol; 2003 Oct; 15(10):1111-4. PubMed ID: 14501620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitivity of fecal hemoccult testing and flexible sigmoidoscopy for colorectal cancer screening.
    Bang KM; Tillett S; Hoar SK; Blair A; McDougall V
    J Occup Med; 1986 Aug; 28(8):709-13. PubMed ID: 3746495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychological Barriers and Facilitators of Colorectal Cancer Screening: A French Qualitative Study.
    Bridou M; Aguerre C; Gimenes G; Kubiszewski V; Le Gall A; Potard C; Sorel O; Reveillere C
    Health Psychol Res; 2013 Apr; 1(2):e22. PubMed ID: 26973907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved screening for colorectal cancer by immunological detection of occult blood.
    Frommer DJ; Kapparis A; Brown MK
    Br Med J (Clin Res Ed); 1988 Apr; 296(6629):1092-4. PubMed ID: 3132220
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.